Product List - APIs

Products
Acebutolol Hydrochloride Buproprion Hydrochloride Cinnarizine Donepezil Hydrochloride Flunarizine Dihydrochloride Gabapentin Gemfibrozil Levetiracetam Memantine Hydrochloride

Therapeutic Areas
Antihypertensive; Antianginal; Antidepressant; Smoking cessation aid Antivertigo Vasodilator Antidementia Antivertigo Anticonvulsant Antilipemic Anticonvulsant Neuroprotective; Antialzheimers Antiparkinsonian

Regulatory Documentation
COS USDMF, Canadian DMF COS, EDMF

CAS
34381-68-5 31677-93-7 298-57-7 120011-70-3

Canadian DMF USDMF, EDMF USDMF, COS USDMF USDMF

30484-77-6 60142-96-3 25812-30-0 102767-28-2 41100-52-1

Ondansetron Hydrochloride Ondansetron Base Pentoxifylline Quetiapine Fumarate Triprolidine Hydrochloride Topiramate Venlafaxine Hydrochloride Ziprasidone

Antiemetic Antiemetic Peripheral Vasodilator Antipsychotic Antihistaminic Anticonvulsant Antidepressant Antipsychotic

USDMF, Canadian DMF,COS USDMF EDMF, COS USDMF USDMF DMF in CTD USDMF, COS --

99614-01-4 99614-02-5 6493-05-6 111974-72-2 6138-79-0 97240-79-4 99300-78-4 146939-27-7

Products under development Aliskiren Carbidopa Dexamethorphan Entacapone Ketoconazole Ketoprofen Levodopa Montelukast sodium Palonosetron Pregabalin Sitagliptin Saxagliptin Tramadol Valacyclovir Valsartan Vildagliptin
USFDA TGA ISO 9001, ISO 14001 & OHSAS 18001 * API/Substances covered by patent are not offered to the countries where the patent law is in force
03/2012

Antihypertensive Antiparkinson Antitussive Antiparkinson Antifungal NSAID Antiparkinson Antihistamine Antiemetic Anticonvulsant, Anxiolytic Antidiabetic Antidiabetic NSAID Antiviral Antihypertensive Antidiabetic

--

173334-58-2 28860-95-9 6700-34-1 130929-57-6 65277-42-1 22071-15-4 59-92-7 151767-02-1 135729-61-2 148553-50-8 486460-32-6 361442-04-8 36282-47-0 124832-26-4 137862-53-4 274901-16-5

Facility inspected by the USFDA in 2004, 2008 and 2011 Facility inspected in 2003 and renewed in 2008 Accredited by Det Norske Veritas AS

www.hikal.com